Fyodor Biotechnologies is a medical device company.
Fyodor is a privately held medical device company whose mission is to develop and commercialize novel medical diagnostic tests that address unmet needs in Nigeria and emerging economies. In response to the large proportion of malaria that is managed at home and in all healthcare settings, Fyodor has developed the Urine Malaria TestTM (UMT) – the first ever non-blood (one-step, no blood, no reagents, no equipment, visually read) rapid test that tells in 25 minutes or less if a fever is due to malaria or not. It removes the complexity, pain and risks associated with a blood test.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 24, 2018 | Seed | — | 1 | — | — | Detail |
May 16, 2018 | Seed | — | 1 | — | — | Detail |
Sep 9, 2013 | Grant | $729.78K | 1 | National Science Foundation | — | Detail |
Aug 14, 2012 | Grant | $571.43K | 1 | National Science Foundation | — | Detail |
Jun 13, 2012 | Grant | $165K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |
The Investment Collective | — | Seed |
500 Global | — | Seed |